Abstract: Lupus tumidus is considered a rare subtype of chronic cutaneous lupus erythematosus, characterized by erythema and bright urticarial erythematous-violaceous lesions that leave no scars after regression. Histopathology reveals perivascular and periannexal lymphohistiocytic infiltrates in the papillary and reticular dermis and interstitial mucin deposition. Treatment is based on photoprotection, topical corticosteroids and antimalarials. We report two cases of lupus tumidus, which deserve attention for their low frequency in the literature, in addition to their relevance as a differential diagnosis among dermatologic disorders.
INTRODUCTION
Lupus erythematosus is a multisystem, heterogeneous, autoimmune disease characterized by the production of autoantibodies against cellular constituents. The most affected organ is the skin, which may be involved in isolation or accompanied by systemic manifestations. 1, 2 It primarily affects young women between 18 and 30 years regardless of racial group. Genetic, environmental, socio-cultural and demographic differences may contribute to differing incidences as well as the clinical expression of the disease. 1, 2 Cutaneous manifestations of lupus can be classified into specific subtypes -which include chronic cutaneous lupus erythematosus (CCLE), subacute cutaneous lupus erythematosus (SCLE) and acute cutaneous lupus erythematosus (ACLE) -and nonspecific skin lesions -such as panniculitis, vasculitis and tumid lesions. 1 However, some authors disagree with this classification claiming that tumid lupus should be considered a separate entity from other forms of lupus, as it shows important responses to treatment with antimalarial drugs, extreme photosensitivity and characteristic histopathologic findings. 3 Lupus tumidus was first described by Gougerot and Bournier in 1930. 4 Clinically, it is characterized by shiny erythematous-violaceous urticarial lesions in sun-exposed areas that leave no scars. 
DISCUSSION
Chronic cutaneous lupus erythematosus (CCLE) has polymorphous presentations that may occasionally mimic other clinical conditions, causing diagnostic difficulties. Lupus tumidus is a rare subtype of CCLE, and its diagnosis can be confirmed by the correlation between clinical and histopathological manifestations. 6 The diagnosis of lupus tumidus is usually delayed, as it can be confused with other dermatoses due to the absence of systemic manifestations. 3 The main differential diagnosis is Jessner's lymphocytic infiltration, which is clinically expressed as asymptomatic papulonodular lesions affecting sun-exposed areas that last for several months and leave no scars when regressing. However, unlike lupus tumidus, histopathology examination reveals no interstitial mucin deposition in Jessner's lymphocytic infiltration. The disease fills the diagnostic criteria for lupus tumidus proposed by Kuhn, which justifies the controversy in the medical literature that question whether Jessner is a lupus tumidus variant or if it is an autonomous entity.
Reticular erythematous mucinosis (REM) -a primitive form of mucinosis that worsens with sun exposure and presents satisfactory response to treatment with antimalarial drugs -should also be listed in the differential diagnosis. Despite the histopathologic similarities to lupus tumidus, the lymphocytic infiltration is usually less dense and mucin accumulates mainly at the papillary dermis in REM. The main difference between the diseases is the clinical manifestation. 3 We suggest systemic antimalarial drugs as the treatment of choice for lupus tumidus. Kind et al. first described effective results with that treatment in 1992. The treatment can also include topical corticosteroids, systemic corticosteroids and high sun protection factor levels (30or higher). 5 Recently, Kuhn et al. described a treatment with photodynamic therapy as an alternative, but it is unable to prevent lesion recurrence. 
